BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 25827291)

  • 1. A randomized trial comparing concurrent chemoradiotherapy with single-agent cisplatin versus cisplatin plus gemcitabine in patients with advanced cervical cancer: An Asian Gynecologic Oncology Group study.
    Wang CC; Chou HH; Yang LY; Lin H; Liou WS; Tseng CW; Liu FY; Liou JD; Huang KG; Huang HJ; Huang EY; Chen CH; Chang TC; Chang CJ; Hong JH; Lai CH
    Gynecol Oncol; 2015 Jun; 137(3):462-7. PubMed ID: 25827291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer.
    Tangjitgamol S; Katanyoo K; Laopaiboon M; Lumbiganon P; Manusirivithaya S; Supawattanabodee B
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010401. PubMed ID: 25470408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial.
    da Costa SCS; Bonadio RC; Gabrielli FCG; Aranha AS; Dias Genta MLN; Miranda VC; de Freitas D; Abdo Filho E; Ferreira PAO; Machado KK; Scaranti M; Carvalho HA; Estevez-Diz MDP
    J Clin Oncol; 2019 Nov; 37(33):3124-3131. PubMed ID: 31449470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix.
    Dueñas-González A; Zarbá JJ; Patel F; Alcedo JC; Beslija S; Casanova L; Pattaranutaporn P; Hameed S; Blair JM; Barraclough H; Orlando M
    J Clin Oncol; 2011 May; 29(13):1678-85. PubMed ID: 21444871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized Phase II study.
    Dueñas-González A; Cetina-Perez L; Lopez-Graniel C; Gonzalez-Enciso A; Gómez-Gonzalez E; Rivera-Rubi L; Montalvo-Esquivel G; Muñoz-Gonzalez D; Robles-Flores J; Vazquez-Govea E; de La Garza J; Mohar A
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):817-23. PubMed ID: 15708261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the progression free survival advantage of concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in patients with advanced cervical cancer worth the additional cost? A cost-effectiveness analysis.
    Smith B; Cohn DE; Clements A; Tierney BJ; Straughn JM
    Gynecol Oncol; 2013 Sep; 130(3):416-20. PubMed ID: 23718933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma.
    Zarbá JJ; Jaremtchuk AV; Gonzalez Jazey P; Keropian M; Castagnino R; Mina C; Arroyo G;
    Ann Oncol; 2003 Aug; 14(8):1285-90. PubMed ID: 12881394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy in high burden locally advanced cervical cancer with concurrent gemcitabine and cisplatin chemoradiotherapy plus adjuvant gemcitabine and cisplatin: prognostic and predictive factors and the impact of disease stage on outcomes from a prospective randomized phase III trial.
    Dueňas-González A; Orlando M; Zhou Y; Quinlivan M; Barraclough H
    Gynecol Oncol; 2012 Sep; 126(3):334-40. PubMed ID: 22691757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial.
    Tangjitgamol S; Tharavichitkul E; Tovanabutra C; Rongsriyam K; Asakij T; Paengchit K; Sukhaboon J; Penpattanagul S; Kridakara A; Hanprasertpong J; Chomprasert K; Wanglikitkoon S; Atjimakul T; Pariyawateekul P; Katanyoo K; Tanprasert P; Janweerachai W; Sangthawan D; Khunnarong J; Chottetanaprasith T; Supawattanabodee B; Lertsanguansinchai P; Srisomboon J; Isaranuwatchai W; Lorvidhaya V
    J Gynecol Oncol; 2019 Jul; 30(4):e82. PubMed ID: 31074236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies.
    Duenas-Gonzalez A; Lopez-Graniel C; Gonzalez-Enciso A; Mohar A; Rivera L; Mota A; Guadarrama R; Chanona G; De La Garza J
    Ann Oncol; 2002 Aug; 13(8):1212-9. PubMed ID: 12181244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
    Whitney CW; Sause W; Bundy BN; Malfetano JH; Hannigan EV; Fowler WC; Clarke-Pearson DL; Liao SY
    J Clin Oncol; 1999 May; 17(5):1339-48. PubMed ID: 10334517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective Analysis of Concurrent Chemoradiation with Triweekly Cisplatin plus 5-Fluorouracil Versus Weekly Cisplatin in Cervical Cancer.
    Sonoda K; Yahata H; Ichinoe A; Okugawa K; Kaneki E; Kawano Y; Kenjo H; Ohgami T; Yagi H; Ohga S; Asai K; Nakamura K; Honda H; Kato K
    Anticancer Res; 2015 Jun; 35(6):3447-54. PubMed ID: 26026109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Outcomes and Sites of Failure in Locally Advanced, Cervical Cancer Patients Treated by Concurrent Chemoradiation with or without Adjuvant Chemotherapy: ACTLACC Trial.
    Tovanabutra C; Asakij T; Rongsriyam K; Tangjitgamol S; Tharavichitkul E; Sukhaboon J; Kridakara LCA; Paengchit K; Khunnarong J; Atjimakul T; Pariyawateekul P; Tanprasert P; Tungkasamit T; Lorvidhaya V
    Asian Pac J Cancer Prev; 2021 Sep; 22(9):2977-2985. PubMed ID: 34582670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: a phase II trial.
    Umanzor J; Aguiluz M; Pineda C; Andrade S; Erazo M; Flores C; Santillana S
    Gynecol Oncol; 2006 Jan; 100(1):70-5. PubMed ID: 16288803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy for locally advanced squamous-cell carcinoma of the cervix: a retrospective analysis from a single institution.
    Kinjyo Y; Nagai Y; Toita T; Kudaka W; Ariga T; Shimoji Y; Nakasone T; Taira Y; Arakaki Y; Nakamoto T; Wakayama A; Ooyama T; Maemoto H; Heianna J; Aoki Y
    Br J Radiol; 2017 Aug; 90(1076):20170241. PubMed ID: 28707541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279.
    Horowitz NS; Deng W; Peterson I; Mannel RS; Thompson S; Lokich E; Myers T; Hanjani P; O'Malley DM; Chung KY; Miller DS; Ueland FR; Dizon DS; Miller A; Mayadev JS; Leath CA; Monk BJ
    J Clin Oncol; 2024 Jun; 42(16):1914-1921. PubMed ID: 38574312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: a Gynecologic Oncology Group study.
    Rose PG; Degeest K; McMeekin S; Fusco N
    Gynecol Oncol; 2007 Nov; 107(2):274-9. PubMed ID: 17688925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin versus gemcitabine as concurrent chemoradiotherapy in squamous cell carcinoma cervix: A comparative study of clinical response and toxicities.
    Singh R; Singh Banipal RP; Goyal LD
    J Cancer Res Ther; 2022; 18(6):1518-1524. PubMed ID: 36412403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
    Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T
    J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of outcomes and side effects for neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation vs. chemoradiation alone in stage IIB-IVA cervical cancer: study protocol for a randomized controlled trial.
    Li J; Liu H; Li Y; Li J; Shen L; Long W; Yang C; Xu H; Xi W; Cai R; Feng W
    Trials; 2022 Jan; 23(1):29. PubMed ID: 35012634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.